Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report for Rhode Island by County

All Cancer Sites (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
County
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
Rhode Island 6 463.3 (458.1, 468.6) N/A 6,329 falling falling trend -0.7 (-0.9, -0.4)
US (SEER+NPCR) 1 442.3 (442.0, 442.6) N/A 1,698,328 stable stable trend -0.3 (-0.6, 0.1)
Kent County 6 504.9 (491.4, 518.6) 1 (1, 2) 1,163 stable stable trend -0.3 (-0.5, 0.0)
Washington County 6 485.3 (470.1, 500.9) 2 (1, 2) 893 falling falling trend -1.0 (-3.3, -0.5)
Bristol County 6 453.5 (430.4, 477.7) 3 (3, 5) 318 stable stable trend -0.4 (-1.0, 0.3)
Newport County 6 449.2 (432.0, 466.9) 4 (3, 5) 573 falling falling trend -1.1 (-1.4, -0.7)
Providence County 6 448.6 (441.7, 455.6) 5 (3, 5) 3,383 falling falling trend -0.8 (-1.3, -0.4)
Notes:
Created by statecancerprofiles.cancer.gov on 03/28/2024 5:28 am.

State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.


Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.

Return to Top